References
- Treshney R I. Induction of differentiation in neoplastic cells. Anticancer Res 1985; 5: 111–30
- Sartorelli A C. Malignant cell differentiation as a potential therapeutic approach. Br J Cancer 1985; 52: 293–302
- Reiss M, Gamba-Vitalo C, Sartorelli A C. Induction of tumor cell differentiation as a therapeutic approach: preclinical models for hematopoietic and solid neoplasms. Cancer Treat Rep 1986; 70: 201–18
- Bloch A. Induced cell differentiation in cancer chemotherapy. Cancer Treat Rep 1984; 69: 199–205
- Spremulli E N, Dexter D L. Polar solvents: a novel class of antineoplastic agents. J Clin Oncol 1984; 2: 227–41
- Marks P A, Rifkind R A. Differentiation modifiers. Cancer 1984; 54: 2766–69
- Tanaka M, Levy J, Terada M, Breslow R, Rifkind R A, Marks P A. Induction of differentiation in murine virus infected erythroleukemia cells by highly polar compounds. Proc Natl Acad Sci USA 1975; 72: 1003–06
- Collins S J, Ruscetti W, Gallacher R E, Gallo R C. Terminal differentiation of human promyelocy-tic leukemia cells induced by dimethylsulfoxide and other polar compounds. Proc Natl Acad Sci USA 1978; 75: 2458–62
- Schubert D, Jacob F. 5-Bromodeoxyuridine-induced differentiation of a neuroblastoma. Proc Natl Acad Sci USA 1970; 67: 247–54
- Palfrey C, Kimhi Y, Littauer U Z, Reuben R C, Marks P A. Induction of differentiation in mouse neuroblastoma cells by hexamethylene bisacetamide. Biochem Biophys Res Commun 1977; 76: 937–42
- Friedman S J, Skehan P. Morphological differentiation of human choriocarcinoma cells induced by methotrexate. Cancer Res 1979; 39: 1960–67
- Strickland S, Sawey M J. Studies on the effect of retinoids on the differentiation of teratocarci-noma stem cells in vitro and in vivo. Dev Biol 1980; 78: 76–85
- Dexter D L, Hager J C. Maturation induction of tumor cells using a human colon carcinoma model. Cancer 1980; 45: 1178–84
- Tralka T S, Rabson A S. Cilia formation in cultures of human lung cancer cells treated with dimethylsulfoxide. J Natl Cancer Inst 1976; 57: 1383–88
- Huberman E, Heckman C, Langenbach R. Stimulation of differentiated function in human melanoma cells by tumor promoting agents and dimethylsulfoxide. Cancer Res 1979; 39: 2618–24
- Braakhuis B JM. Transplantation of human head and neck xenografts in athymic nude mice: a potential screening model for anticancer drugs. Free University of Amsterdam: Thesis. 1987
- Braakhuis B JM, Sneeuwloper G, Snow G B. The potential of the nude mouse xenograft model for the study of head and neck cancer. Arch Otorhinolaryngol 1983; 239: 69–79
- Braakhuis B JM, Leyva A, Schoevers E J, Boerrigter G H, Schornagel J H, Snow G B. Lack of effect of methotrexate on human head and neck tumours transplanted in athymic nude mice. Acta Otolaryngol (Stockh) 1985; 99: 208–13
- Virolainen E, Vanharanta R, Carey T E. Steroid hormone receptors in human squamous carcinoma cell lines. Int J Cancer 1984; 33: 19–25
- Kopper L, Steel G G. The therapeutic response of three human tumour lines maintained in immune-suppressed mice. Cancer Res 1975; 35: 2704–13
- Hong W K, Bromer R. Chemotherapy in head and neck cancer. N Engl J Med 1983; 308: 333–40
- Speers W C. Conversion of malignant murine embryonal carcinomas to benign teratomas by chemical induction of differentiation in vivo. Cancer Res 1982; 42: 1843–49
- Kimmel K A, Carey T E. Altered expression in squamous carcinoma cells of an orientation restricted epithelial antigen detected by monoclonal antibody A9. Cancer Res 1986; 46: 3614–23
- Boheim K, Schwarzfurtner H, Boheim C, Frei E, Bernal S D. Immunohistochemical identification of squamous carcinoma of the head and neck with monoclonal antibody SQM1. Acta Otolaryngol (Stockh) 1986; 102: 333–40